Androgens are known to stimulate lipogenesis in prostate cancer cells directly by increasing the transcription of specific genes encoding lipogenic enzymes, such as the fatty acid synthase (FAS) and HMG-CoA reductase [22], [23]. This evidence concerns the gene FASN and prostate cancer.